Save This Listing
Stumble It
Reporter Account  Create New Account  Login!
Search :
QUICK LINKS : Art & Entertainment Automotive Blogging & Social Media Business Computer Design Education Environment Events / Trade Shows  
For PR Writing Services
forpressrelease.com
shop now
forpressrelease.com
 
 
 
Press Release Details    
Add to Favorites  Mail to a Friend Print Page   Share This News Rate
Save This Listing     Stumble It          
113

Global Cancer Generic Drugs Market to Post 26% CAGR in 2011-2015

According to a new report by RNCOS, the global cancer generics market has been witnessing a significant level of growth in recent times. The market is well supported by the patent expiries of blockbuster branded drugs that fetched billion of dollars worth sales potential. Though generic drugs currently account for miniscule share of overall oncology market, their contribution is likely to augment in future. Further, it is estimated that the market for cancer generics will grow at a healthy CAGR of around 26% during 2011-2015. Market players, such as Teva, Accord Healthcare, Mylan, and Sun Pharmaceuticals will witness an increase in the uptake of their generic drugs, especially in the US market, which is gripped in the shortage of oncology drugs.

Research Analysis & Highlights

The report entitled “Cancer Generics Market Analysis”, provides an extensive research and in-depth analysis of the current status and expected position of the global cancer generics market. It evaluates the current status and future potential of generic drugs in most common cancers worldwide, such as lung cancer, breast cancer, colon cancer, stomach cancer, and prostate cancer.

Moreover, the report projects the future size of overall cancer generic drug market till the 2015. In this context, it illustrates the market drivers, key developments, and restraints that may impact the market in an effective manner. A brief description of active market players has also been provided.

Some of the report’s key highlights include:

- Generic drugs for Colon Cancer Shall Boost the Market in Future
- Patent Expiries Driving the Growth in Cancer Generic Drugs
- Drug Shortages in the US Calls for Enhancing Manufacturing Capabilities

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM353.htm

Some of our Related Reports are:

- Japan Generics Market Analysis (http://www.rncos.com/Report/IM371.htm)
- Generic Drug Market in Canada (http://www.rncos.com/Report/IM598.htm)
- Booming Generics Drug Market in India (http://www.rncos.com/Report/IM256.htm)
- UK Generics Market Analysis (http://www.rncos.com/Report/IM313.htm)
- Booming US Generic Drug Market (http://www.rncos.com/Report/IM589.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.  
 
 

Contact Information

  • Name: Shushmul Maheshwari

    Company: RNCOS E-Services Pvt. Ltd.

    Telphone: 91-120-4224700 , -

    Address: B-129, Sector 6 Noida - 201301

    Email: press@rncos.com